Authors: Lastres-Becker, I Fezza, F Cebeira, M Bisogno, T Ramos, JA Milone, A Fernandez-Ruiz, JA Di Marzo, V

Citation: I. Lastres-becker et al., Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease, NEUROREPORT, 12(10), 2001, pp. 2125-2129

Authors: Hansen, HH Schmid, PC Bittigau, P Lastres-Becker, I Berrendero, F Manzanares, J Ikonomidou, C Schmid, HHO Fernandez-Ruiz, JJ Hansen, HS

Citation: Hh. Hansen et al., Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration, J NEUROCHEM, 78(6), 2001, pp. 1415-1427

Authors: Di Marzo, V Lastres-Becker, I Bisogno, T De Petrocellis, L Milone, A Davis, JB Fernandez-Ruiz, JJ

Citation: V. Di Marzo et al., Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues, EUR J PHARM, 420(2-3), 2001, pp. 123-131

Authors: Lastres-Becker, I Romero, J Berrendero, F Perez-Rosado, A Manzanares, J Rojo, A Fernandez-Ruiz, J de Yebenes, JG Ramos, JA

Citation: I. Lastres-becker et al., Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neuronsincreased cannabinoid CB1 receptor mRNA levels in the rat striatum: Possible therapeutic implications, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 301-305

Authors: Gonzalez, S Romero, J de Miguel, R Lastres-Becker, I Villanua, MA Makriyannis, A Ramos, JA Fernandez-Ruiz, JJ

Citation: S. Gonzalez et al., Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide, LIFE SCI, 65(3), 1999, pp. 327-336